Nurix Therapeutics (NRIX) News Today $10.51 -0.87 (-7.64%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$10.51 0.00 (0.00%) As of 08:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Nurix Therapeutics (NASDAQ:NRIX) Shares Down 8.9% - Should You Sell?Nurix Therapeutics (NASDAQ:NRIX) Stock Price Down 8.9% - Here's What HappenedApril 3 at 12:11 PM | marketbeat.comNurix Therapeutics (NRIX) Projected to Post Earnings on WednesdayNurix Therapeutics (NASDAQ:NRIX) will be releasing earnings before the market opens on Wednesday, April 9, Financial Modeling Prep reports.April 3 at 1:22 AM | marketbeat.com5NRIX : Expert Outlook: Nurix Therapeutics Through The Eyes Of 9 AnalystsApril 2 at 11:52 PM | benzinga.comNurix Therapeutics in Expanded Collaboration with SanofiApril 2 at 8:49 AM | marketwatch.comNurix Licenses a Drug Discovery Program to Sanofi Targeting a Novel Transcription Factor for Autoimmune DiseasesApril 2 at 7:00 AM | globenewswire.comNEOS Investment Management LLC Acquires Shares of 22,557 Nurix Therapeutics, Inc. (NASDAQ:NRIX)NEOS Investment Management LLC acquired a new stake in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 22,557 shares of the company's stock,April 2 at 4:15 AM | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Hits New 12-Month Low - What's Next?Nurix Therapeutics (NASDAQ:NRIX) Reaches New 1-Year Low - Here's WhyApril 1 at 12:45 PM | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) and Verastem (NASDAQ:VSTM) Head to Head ContrastApril 1 at 2:31 AM | americanbankingnews.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Receives $30.88 Average PT from BrokeragesMarch 30, 2025 | americanbankingnews.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) have been given an average rating of "Moderate Buy" by the eighteen ratings firms that are covering the firm, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation and fifteen have issued aMarch 27, 2025 | marketbeat.com19,952 Shares in Nurix Therapeutics, Inc. (NASDAQ:NRIX) Bought by Proficio Capital Partners LLCProficio Capital Partners LLC purchased a new stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 19,952 shares of the company's stock, valued at approximately $37March 26, 2025 | marketbeat.comNurix Therapeutics Announces Multiple Presentations at the American Association for Cancer Research (AACR) 2025 Annual MeetingMarch 25, 2025 | globenewswire.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Acquired by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. lifted its position in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 11.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 572,834 shares of the company's stock after buying aMarch 23, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Trading Down 6.2% - Here's What HappenedNurix Therapeutics (NASDAQ:NRIX) Shares Down 6.2% - Time to Sell?March 22, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Trading Up 4.4% - What's Next?Nurix Therapeutics (NASDAQ:NRIX) Trading Up 4.4% - Here's What HappenedMarch 21, 2025 | marketbeat.comQ3 Earnings Estimate for NRIX Issued By Leerink PartnrsNurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) - Stock analysts at Leerink Partnrs issued their Q3 2025 earnings estimates for Nurix Therapeutics in a research note issued to investors on Monday, March 17th. Leerink Partnrs analyst F. Khurshid forecasts that the company will post earnings oMarch 21, 2025 | marketbeat.comPrimecap Management Co. CA Has $4.37 Million Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Primecap Management Co. CA trimmed its holdings in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 20.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 232,000 shares of the company's stock after seMarch 21, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Upgraded to "Hold" at Leerink PartnrsLeerink Partnrs raised Nurix Therapeutics to a "hold" rating in a research report on Monday.March 20, 2025 | marketbeat.comQ1 Earnings Forecast for NRIX Issued By Leerink PartnrsNurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) - Research analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for Nurix Therapeutics in a report issued on Monday, March 17th. Leerink Partnrs analyst F. Khurshid forecasts that the company will post earnings of ($0.89) per share foMarch 20, 2025 | marketbeat.comVictory Capital Management Inc. Increases Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Victory Capital Management Inc. boosted its stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 179.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 60,212 shares of the company's stock after purchasingMarch 20, 2025 | marketbeat.comBeyond The Numbers: 8 Analysts Discuss Nurix Therapeutics StockMarch 19, 2025 | benzinga.comNurix Therapeutics (NASDAQ:NRIX) Now Covered by Analysts at Leerink PartnersLeerink Partners assumed coverage on shares of Nurix Therapeutics in a research note on Monday. They issued a "market perform" rating and a $16.00 target price on the stock.March 18, 2025 | marketbeat.comNikko Asset Management Americas Inc. Raises Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Nikko Asset Management Americas Inc. boosted its position in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 42.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 789,222 shaMarch 18, 2025 | marketbeat.comLeerink Partners Initiates Coverage of Nurix Therapeutics (NRIX) with Market Perform RecommendationMarch 17, 2025 | msn.comNurix Gets FDA Orphan Designation for Bexobrutideg in Waldenstrom MacroglobulinemiaMarch 17, 2025 | marketwatch.comNurix Therapeutics initiated with a Market Perform at LeerinkMarch 17, 2025 | markets.businessinsider.comNurix Therapeutics announces FDA ODD granted to bexobrutidegMarch 17, 2025 | markets.businessinsider.comNurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (NX-5948) for the Treatment of Waldenström MacroglobulinemiaMarch 17, 2025 | globenewswire.comNurix Therapeutics grants stock options to new hiresMarch 16, 2025 | investing.comNurix Therapeutics expands board with oncology veteranMarch 15, 2025 | investing.comNurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 14, 2025 | globenewswire.comNurix Therapeutics (NASDAQ:NRIX) Shares Down 6.9% - Here's WhyNurix Therapeutics (NASDAQ:NRIX) Stock Price Down 6.9% - Time to Sell?March 14, 2025 | marketbeat.comNurix Therapeutics treatment of Waldenstrom macroglobulinemia gets orphan statusMarch 13, 2025 | markets.businessinsider.comNurix Therapeutics Appoints Drug Development Expert Roy D. Baynes, MB.Bch.March 13, 2025 | globenewswire.comProficio Capital Partners LLC Makes New Investment in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Proficio Capital Partners LLC purchased a new position in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 19,952 shares of the company'sMarch 11, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by Candriam S.C.A.Candriam S.C.A. reduced its stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 40.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 634,626 shares of the company's stock after selling 427,333 shares during the quMarch 8, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) CFO Sells $84,404.25 in StockNurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) CFO Houte Hans Van sold 5,825 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $14.49, for a total transaction of $84,404.25. Following the sale, the chief financial officer now directly owns 33,724 shares in the company, valued at approximately $488,660.76. This trade represents a 14.73 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.March 4, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Shares Down 6% - Should You Sell?Nurix Therapeutics (NASDAQ:NRIX) Shares Down 6% - Here's What HappenedMarch 4, 2025 | marketbeat.comNurix Therapeutics to Participate in Upcoming Investor ConferencesMarch 4, 2025 | globenewswire.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesShares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) have been given a consensus rating of "Moderate Buy" by the sixteen brokerages that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and fifteen have assignedMarch 2, 2025 | marketbeat.comARK Investment Management LLC Sells 686,072 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX)ARK Investment Management LLC lowered its position in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 31.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,530,293 shares of theFebruary 26, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Reduces Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Allspring Global Investments Holdings LLC lessened its stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 35.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 89,920 shares of the company's stock after selling 50,353 sharesFebruary 23, 2025 | marketbeat.comNurix Therapeutics: A Story To MonitorFebruary 18, 2025 | seekingalpha.comNurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)February 14, 2025 | globenewswire.comSumitomo Mitsui Trust Group Inc. Raises Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Sumitomo Mitsui Trust Group Inc. lifted its stake in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 42.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 789,222 shares of the company's stock after acquiring an aFebruary 13, 2025 | marketbeat.comNurix Therapeutics (NRIX) Projected to Post Quarterly Earnings on ThursdayNurix Therapeutics (NASDAQ:NRIX) will be releasing earnings on Thursday, February 20, Financial Modeling Prep reports.February 13, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Average Recommendation of "Moderate Buy" from AnalystsNurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the seventeen analysts that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and sixteen have given aFebruary 5, 2025 | marketbeat.comNurix Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 4, 2025 | globenewswire.comNurix Therapeutics price target raised to $17 from $16 at Morgan StanleyFebruary 3, 2025 | markets.businessinsider.comTruist Financial Sticks to Their Buy Rating for Nurix Therapeutics (NRIX)February 3, 2025 | markets.businessinsider.com Remove Ads Get Nurix Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NRIX and its competitors with MarketBeat's FREE daily newsletter. Email Address NRIX Media Mentions By Week NRIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRIX News Sentiment▼0.450.61▲Average Medical News Sentiment NRIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRIX Articles This Week▼106▲NRIX Articles Average Week Remove Ads Get Nurix Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NRIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACLX News RNA News RARE News RYTM News SWTX News AKRO News CRNX News SRRK News PTGX News CPRX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRIX) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nurix Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nurix Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NRIX Stock Free NRIX Stock Alerts